P D Hoeprich

Author PubWeight™ 122.27‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Metachromatic agar-diffusion methods for detecting staphylococcal nuclease activity. Appl Microbiol 1971 10.60
2 Obfuscation of the activity of antifungal antimicrobics by culture media. J Infect Dis 1972 7.47
3 Nuclease production and lysostaphin susceptibility of Staphylococcus aureus and other catalase-positive cocci. Appl Microbiol 1971 3.40
4 Gentamicin therapy in renal failure: a nomogram for dosage. Ann Intern Med 1972 2.43
5 Effect of culture media on the antifungal activity of miconazole and amphotericin B methyl ester. J Infect Dis 1976 2.31
6 Diagnostic usefulness and safety of transtracheal aspiration. N Engl J Med 1967 2.23
7 Susceptibility of three groups of Staphylococcus aureus to newer antimicrobial agents. Antimicrob Agents Chemother 1977 2.09
8 Problems in the diagnosis and treatment of systemic candidiasis. J Infect Dis 1972 1.83
9 Miconazole therapy for coccidioidomycosis. JAMA 1974 1.81
10 Penetration of antimicrobial agents into bronchial secretions. Am J Med 1975 1.74
11 Itraconazole treatment of phaeohyphomycosis. J Am Acad Dermatol 1990 1.57
12 Prediction of antimeningococcic chemoprophylactic efficacy. J Infect Dis 1971 1.55
13 Comparison of amphotericin B and amphotericin B methyl ester: efficacy in murine coccidioidomycosis and toxicity. J Infect Dis 1976 1.52
14 Susceptibility of coccidioides immitis, Candida albicans, and Cryptococcus neoformans to amphotericin B, flucytosine, and clotrimazole. J Infect Dis 1975 1.50
15 Effect of buffers on testing of Candida species susceptibility to flucytosine. J Clin Microbiol 1987 1.44
16 Chemotherapy of systemic fungal diseases. Annu Rev Pharmacol Toxicol 1978 1.39
17 Development of resistance to 5-fluorocytosine in Candida parapsilosis during therapy. J Infect Dis 1974 1.38
18 Experimental and clinical aspects of resistance determinants. Mode of resistance against beta-lactam antibiotics in staphylococci. Ann N Y Acad Sci 1971 1.36
19 Gentamicin versus staphylococcus aureus. J Infect Dis 1969 1.36
20 Disk agar diffusion susceptibility testing of yeasts. Antimicrob Agents Chemother 1978 1.35
21 Thermonuclease seroinhibition test for distinguishing Staphylococcus aureus from other coagulase-positive staphylococci. J Clin Microbiol 1979 1.32
22 Synthetic medium for susceptibility testing. Antimicrob Agents Chemother (Bethesda) 1970 1.31
23 Influence of culture medium on susceptibility testing with BAY n 7133 and ketoconazole. J Clin Microbiol 1986 1.30
24 An unusual outbreak of windborne coccidioidomycosis. N Engl J Med 1979 1.27
25 Bacteriology of the lower respiratory tract as determined by fiber-optic bronchoscopy and transtracheal aspiration. J Infect Dis 1976 1.23
26 Metachromatic agar-diffusion microslide technique for detecting staphylococcal nuclease in foods. Appl Microbiol 1972 1.20
27 Nocardial brain abscess cured with cycloserine and sulfonamides. Am J Med Sci 1968 1.20
28 Occurrence of protein A in Staphylococcus aureus and closely related Staphylococcus species. J Clin Microbiol 1979 1.18
29 Stability of four antifungal antimicrobics in vitro. J Infect Dis 1978 1.17
30 Effect of tetracycline, polymyxin B, and rifampin on phagocytosis. Clin Pharmacol Ther 1970 1.17
31 Distribution of doubly radiolabelled amphotericin B methyl ester and amphotericin B in the non-human primate, Macaca mulatta. J Antimicrob Chemother 1980 1.16
32 Comparative pharmacology of amphotericin B and amphotericin B methyl ester in the non-human primate, Macacca mulatta. Antimicrob Agents Chemother 1977 1.15
33 Convenient assay for staphylococcal nuclease by the metachromatic well-agar-diffusion technique. Appl Microbiol 1972 1.10
34 Treatment of open fractures: a prospective study. J Trauma 1983 1.10
35 Nafcillin concentration in cerebrospinal fluid during treatment of staphylococcal infections. Ann Intern Med 1977 1.08
36 Susceptibility of "methicillin"-resistant Staphylococcus aureus to 12 antimicrobial agents. Antimicrob Agents Chemother (Bethesda) 1969 1.05
37 Effect of nitrogen dioxide on pulmonary bacterial defense mechanisms. Arch Environ Health 1973 1.05
38 Infective endocarditis caused by Streptococcus bovis resistant to the lethal effect of penicillin G. Arch Intern Med 1978 1.03
39 Tolerance of staphylococcal thermonuclease to stress. Appl Microbiol 1972 1.03
40 The HTLV-III envelope protein contains a hexapeptide homologous to a region of interleukin-2 that binds to the interleukin-2 receptor. Biochem Biophys Res Commun 1986 1.02
41 Acquired and native resistance of Staphylococcus aureus to cephalexin and other beta-lactam antibiotics. Appl Microbiol 1970 1.01
42 Induction of resistance in Staphylococcus aureus and Klebsiella pneumoniae by exposure to cephalothin and cefoxitin. J Infect Dis 1976 1.00
43 Comparative acute toxicity of four drugs. A study of neomycin, gentamicin, kanamycin, and dihydrostreptomycin. Arch Intern Med 1967 0.99
44 Dimeric half-molecules of human fibrinogen are joined through disulfide bonds in an antiparallel orientation. Biochemistry 1983 0.98
45 Successful treatment of gram-negative bacillary meningitis with moxalactam. Ann Intern Med 1981 0.98
46 The polymyxins. Med Clin North Am 1970 0.97
47 Grouping of gram-negative bacteria and susceptibility to antimicrobial agents. Antimicrob Agents Chemother (Bethesda) 1965 0.94
48 In vitro activities of two new antifungal azoles. Antimicrob Agents Chemother 1984 0.94
49 Adverse influence of ozone on pulmonary bactericidal activity of murine lung. Nature 1971 0.94
50 Postoperative infection of an aortic prosthesis with Achromobacter xylosoxidans. West J Med 1982 0.94
51 Susceptibility of staphylococci to new antimicrobial agents. Antimicrob Agents Chemother (Bethesda) 1967 0.93
52 Evidence for a role of the amino-terminal region in the biological activity of the classical anaphylatoxin, porcine C5a des-Arg-74. J Biol Chem 1985 0.91
53 Providence bacillus bacteremia and septicopyemia. Am J Med 1968 0.91
54 Comparative susceptibility of four kinds of pathogenic fungi to amphotericin B and amphotericin B methyl ester. Antimicrob Agents Chemother 1978 0.91
55 Reproducible method for induction of pulmonary coccidioidomycosis in mice. J Infect Dis 1977 0.90
56 Purification of High Titer Tetanus Toxin. J Bacteriol 1945 0.90
57 In vitro susceptibilities of Naegleria fowleri strain HB-1 to selected antimicrobial agents, singly and in combination. Antimicrob Agents Chemother 1979 0.88
58 Acquisition of coccidioidomycosis at necropsy by inhalation of coccidioidal endospores. Diagn Microbiol Infect Dis 1992 0.88
59 Recovery from encephalomyelitis caused by Herpesvirus simiae. Report of a case. Arch Intern Med 1975 0.88
60 Ozone and the antibacterial defense mechanisms of the murine lung. Arch Intern Med 1971 0.88
61 Parenteral sodium ampicillin therapy of endocarditis, salmonellosis, and other bacterial infections. Antimicrob Agents Chemother (Bethesda) 1965 0.88
62 Reliability of a commercial triphenyltetrazolium chloride reduction test for detecting significant bacteriuria. Am J Med Sci 1966 0.87
63 Entry of four cephalosporins into the ovine lung. J Infect Dis 1984 0.87
64 Shigellemia. West J Med 1984 0.87
65 Etiologic diagnosis of lower respiratory tract infections. Calif Med 1970 0.86
66 Cold sterilization of ureteral catheters with ethylene oxide gas. J Urol 1966 0.86
67 Antibodies that neutralize human beta interferon biologic activity recognize a linear epitope: analysis by synthetic peptide mapping. Proc Natl Acad Sci U S A 1991 0.85
68 Entry of four tetracyclines into saliva and tears. Antimicrob Agents Chemother 1974 0.85
69 Toxicity of amphotericins on chronic administration to mongrel dogs. Diagn Microbiol Infect Dis 1985 0.84
70 In vitro activity of cephalothin and three penicillins against Escherichia coli and Proteus species. Antimicrob Agents Chemother 1973 0.84
71 The penicillins, old and new. Review and perspectives. Calif Med 1968 0.83
72 New antifungal drugs in the therapy of systemic mycoses. Scand J Infect Dis Suppl 1978 0.82
73 Analysis of bacterial isolates from cerebrospinal fluid. J Clin Microbiol 1984 0.81
74 A synthetic nonapeptide corresponding to the NH2-terminal sequence of C3d-K causes leukocytosis in rabbits. J Biol Chem 1985 0.81
75 Engulfment and bactericidal capabilities of peripheral blood leukocytes in chronic leukemias. Cancer 1969 0.81
76 The effects of anesthetic agents on murine pulmonary bactericidal activity. Anesthesiology 1971 0.80
77 Quantitative microbiology of traumatic orthopedic wounds. J Clin Microbiol 1978 0.80
78 Influence of culture media on the antistaphylococcal activity of fosfomycin. Appl Microbiol 1971 0.80
79 Cellular receptors to the anaphylatoxins C3a and C5a. Biochem Soc Symp 1986 0.79
80 Typhoid fever caused by chloramphenicol-resistant organisms. JAMA 1973 0.79
81 Diagnostic value of gallium and bone scans in evaluation of extrapulmonary coccidioidal lesions. Am Rev Respir Dis 1980 0.79
82 Antifungal chemotherapy. Prog Drug Res 1995 0.78
83 New antimicrobics for the treatment of infections caused by gram-negative bacilli. Med Clin North Am 1967 0.77
84 Influence of anesthetic agents on murine pulmonary bactericidal activity. Antimicrob Agents Chemother (Bethesda) 1970 0.77
85 Effect of cycloserines on D-amino acid oxidase. Arch Biochem Biophys 1966 0.77
86 Entry of five antifungal agents into the ovine lung. Antimicrob Agents Chemother 1987 0.76
87 The changing face of pneumonia. Hosp Pract 1979 0.76
88 Treatment of coccidioidomycosis with miconazole. JAMA 1980 0.76
89 Activity of BAY n 7133 and BAY 1 9139 in vitro and in experimental murine coccidioidomycosis. Eur J Clin Microbiol 1985 0.76
90 Effect of vitamin E and ozone on the pulmonary antibacterial defense mechanisms. J Lab Clin Med 1974 0.76
91 Bioactive complement fragments in immunoregulation. Immunol Lett 1985 0.76
92 Helical conformation at the carboxy-terminal portion of human C3a is required for full activity. Biochemistry 1986 0.76
93 Tracheobronchial flora in chronic obstructive pulmonary disease: preliminary results with authentic specimens and trial of trimethoprim-sulfamethoxazole. J Infect Dis 1973 0.76
94 Long-term venous access in rhesus monkeys. Antimicrob Agents Chemother 1982 0.75
95 Totally synthetic medium for susceptibility testing. Antimicrob Agents Chemother 1978 0.75
96 Lymphangiography in diagnosis of fever of unknown origin. Calif Med 1973 0.75
97 Pericarditis caused by beta-lactamase-producing Haemophilus influenzae: report of two cases in adults and review of the literature. Tex Heart Inst J 1986 0.75
98 Illicit intravenous drug use and bacterial endocarditis. Calif Med 1973 0.75
99 Trimethoprim-sulfamethoxazole in chronic bronchitis. Can Med Assoc J 1975 0.75
100 Activity of two polyene and two imidazole antimicrobics on Candida albicans in human fibrin clots. J Lab Clin Med 1983 0.75
101 Ovine pulmonary transit of tetracycline and minocycline. Diagn Microbiol Infect Dis 1987 0.75
102 Microbial development of drug resistance: mechanisms and clinical significance. CRC Crit Rev Clin Lab Sci 1975 0.75
103 Ketoconazole in systemic mycoses. Ann Intern Med 1983 0.75
104 In search of a word. J Infect Dis 1971 0.75
105 Comparative efficacy of forphenicinol, cyclosporine, and amphotericin B in experimental murine coccidioidomycosis. Diagn Microbiol Infect Dis 1987 0.75
106 Chemotherapy for systemic mycoses. Prog Drug Res 1989 0.75
107 Bear meat trichinosis with a concomitant serologic response to Toxoplasma gondii. Am J Med Sci 1975 0.75
108 Successful treatment of progressive disseminated histoplasmosis with amphotericin B methyl ester. Diagn Microbiol Infect Dis 1989 0.75
109 Multifocal systemic sporotrichosis with lobar pulmonary involvement. Scand J Infect Dis 1988 0.75
110 Current principles of antimicrobic therapy. Obstet Gynecol 1980 0.75
111 Choice among the penicillins. Proc Inst Med Chic 1975 0.75
112 Treatment of salmonellosis. N Engl J Med 1968 0.75
113 Influence of ozone on pulmonary defense mechanisms of silicotic mice. Arch Environ Health 1972 0.75
114 Elimination half-life of amphotericin B. J Infect 1990 0.75
115 The fever of neoplasia. GP 1968 0.75
116 Cephaloridine therapy of endocarditis and other life-threatening infections. Antimicrob Agents Chemother (Bethesda) 1967 0.75
117 Use of radiologic modalities in coccidioidal meningitis. Arch Intern Med 1981 0.75
118 A simple method for detecting significant bacteriuria. Am J Med Sci 1967 0.75
119 Chemoprophylaxis of infection in patients receiving steroids, irradiation and cytotoxic agents. Med Times 1969 0.75
120 Transtracheal aspiration in diagnosis of lower respiratory tract diseases. Antimicrob Agents Chemother (Bethesda) 1965 0.75